On the Economic Burden of MRSA in Germany

被引:10
作者
Claus, F. [1 ]
Sachse, A. [2 ]
Ried, W. [1 ]
机构
[1] Ernst Moritz Arndt Univ Greifswald, Lehrstuhl Allgemeine Volkswirtschaftslehre & Fina, D-17489 Greifswald, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Lehrstuhl Allgemeine Betriebswirtschaftslehre & G, D-17489 Greifswald, Germany
关键词
economic burden; cost of illness; MRSA; multidrug resistant bacteria; health-related quality of life; RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; MANAGEMENT; OUTCOMES; IMPACT; COSTS;
D O I
10.1055/s-0034-1381987
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Methicillin-resistant S. aureus (MRSA) usually exhibits resistance not only against beta-lactam antibiotics but also against other classes of antibiotics with the result that infections caused by this bacterium are difficult to treat. Due to additional morbidity and mortality a high economic burden can be expected. Aim: The aim of this study was to outline the cost effects caused by MRSA colonisation and infections and to quantify the annual economic burden in Germany by using published data in order to assess the costs due to MRSA in Germany. Methods: Based on the available literature we estimated tangible and intangible costs per patient associated with MRSA. Total costs were calculated using data of the MRSA-KISS and the Federal Bureau of Statistics as well as other prevalence data. These costs are shown in prices of the year 2011. Results: Direct costs occurring in German hospitals are estimated to be between 354.29 million (sic) and 1.55 billion (sic). Productivity losses due to an extended duration of disease are evaluated to be at least 92.77 million (sic) while lost quality adjusted life years due to MRSA infections are estimated at 0.292* t per infected patient (where t denotes the time of the associated health impairment). Conclusion: It is not possible to quantify the total cost of illness caused by MRSA in Germany due to a lack of data on some of the direct costs (e.g., in rehabilitation facilities) as well as on the indirect and intangible costs. Nevertheless it can be shown that colonisation and infections caused by MRSA impose high costs on the health-care system and the whole economy as well.
引用
收藏
页码:800 / 806
页数:7
相关论文
共 35 条
  • [1] [Anonymous], 2014, PPPS EXCH RAT
  • [2] The burden of MRSA in four German university hospitals
    Chaberny, IF
    Ziesing, S
    Mattner, F
    Bärwolff, S
    Brandt, C
    Eckmanns, T
    Rüden, H
    Sohr, D
    Weist, K
    Gastmeier, P
    [J]. INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2005, 208 (06) : 447 - 453
  • [3] Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia:: A meta-analysis
    Cosgrove, SE
    Sakoulas, G
    Perencevich, EN
    Schwaber, MJ
    Karchmer, AW
    Carmeli, Y
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) : 53 - 59
  • [4] Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection
    Engemann, JJ
    Carmeli, Y
    Cosgrove, SE
    Fowler, VG
    Bronstein, MZ
    Trivette, SL
    Briggs, JP
    Sexton, DJ
    Kaye, KS
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) : 592 - 598
  • [5] European Centre for Disease Prevention and Control, 2012, ANT RES SURV EUR 201
  • [6] Greiner B F, 2007, THESIS TU MUNCHEN MU
  • [7] Greiner W., 2012, Gesundheitskonomische Evaluationen, P23, DOI [10.1007/978-3-642-21700-53, DOI 10.1007/978-3-642-21700-53]
  • [8] Increased mortality associated with meticillin-resistant Staphylococcus aureus (MRSA) infection in the Intensive Care Unit: results from the EPIC II study
    Hanberger, Hakan
    Walther, Sten
    Leone, Marc
    Barie, Philip S.
    Rello, Jordi
    Lipman, Jeffrey
    Marshall, John C.
    Anzueto, Antonio
    Sakr, Yasser
    Pickkers, Peter
    Felleiter, Peter
    Engoren, Milo
    Vincent, Jean-Louis
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (04) : 331 - 335
  • [9] Henrich G., 2000, Lebensqualitt und Gesundheitskonomie in der Medizin. Konzepte, Methoden, Anwendung, P98
  • [10] Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward
    Herr, CEW
    Heckrodt, TH
    Hofmann, FA
    Schnettler, R
    Eikmann, TF
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (09) : 673 - 678